# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-25-001821
Filing Date
2025-01-08
Accepted
2025-01-08 06:30:00
Documents
6
Period of Report
2025-01-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | tm252001-1_pre14a.htm | PRE 14A | 875784
2 | GRAPHIC | lg_cyclacel-4clr.jpg | GRAPHIC | 17219
3 | GRAPHIC | lg_secretarysoffistamp-bwlr.jpg | GRAPHIC | 13622
4 | GRAPHIC | px_cyclacel25pg01-4c.jpg | GRAPHIC | 320193
5 | GRAPHIC | px_cyclacel25pg02-4c.jpg | GRAPHIC | 176657
6 | GRAPHIC | sg_jeffreywbullock-bw.jpg | GRAPHIC | 10632
| Complete submission text file | 0001104659-25-001821.txt |  | 1555263

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-50626 | Film No.: 25516526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)